Contraindicated. Coadministration of doravirine with a strong CYP3A inducer may possibly lower doravirine plasma concentrations and/or effects. Potential for loss of virologic response and probable resistance to doravirine. Watch Closely (1)pentobarbital will lower the extent or result of tofacit